By Professor Graham Jones

Journal articles

Jones GRD, 2026, 'Supporting Correct Use of Reference Intervals—An Ongoing Saga', The Journal of Applied Laboratory Medicine, pp. jfag146, http://dx.doi.org/10.1093/jalm/jfag146

Farrell C-JL; Loh TP; Badrick T; Jones GRD; Horvath AR, 2026, 'An improved approach to modelling patient reclassification: HbA1c as an example', Clinical Chemistry and Laboratory Medicine, http://dx.doi.org/10.1515/cclm-2026-0259

Wehbe E; Sreeharan T; Sutrave G; Bui J; Lau C; Park JY; Sandaradura I; Darley D; Macdonald P; Milliken S; Fung JN; Jones G; Kizny Gordon A; Kliman D; Lu CY; Marriott D; Alffenaar JWC; Stocker SL, 2026, 'Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy', Journal of Antimicrobial Chemotherapy, 81, http://dx.doi.org/10.1093/jac/dkag168

Badrick T; Beasley-Green A; Cobbaert CM; Delatour V; Deprez L; Jones GRD; Josephs RD; Kessler A; Liu Q; Maniguet S; Miller WG; Roberts GV; Sandberg S; Van Rossum HH; Van Uytfanghe K; Vogl C; Wielgosz R; Zhang T; Panteghini M, 2026, 'Result harmonization in medical laboratories: accomplishments and challenges.', Clin Chem Lab Med, 64, pp. 1201 - 1209, http://dx.doi.org/10.1515/cclm-2026-0323

Jones GRD, 2026, 'Limitations to the development of Milan model 1b analytical performance specifications.', Clin Chem Lab Med, http://dx.doi.org/10.1515/cclm-2026-0377

Røys EÅ; Viste K; Farrell CJ; Kellmann R; Alaour B; Sylte MS; Torsvik J; Strand H; Marber M; Omland T; Theodorsson E; Jones GRD; Aakre KM, 2025, 'A Parametric Empirical Bayes Approach to Personalized Reference Intervals and Reference Change Values', Clinical Chemistry, 71, pp. 1147 - 1157, http://dx.doi.org/10.1093/clinchem/hvaf092

Adams LA; Kemp WW; Muller KR; Powell EE; Roberts SK; Bertot LC; Best S; Deed G; Emery JD; Hocking SL; Jones GR; Lubel JS; Sheils S; Twigg SM; Watts GF; George J, 2025, 'Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summary', Medical Journal of Australia, 223, pp. 268 - 276, http://dx.doi.org/10.5694/mja2.70008

Røys EÅ; Viste K; Farrell CJ; Kellmann R; Guldhaug NA; Theodorsson E; Jones GRD; Aakre KM, 2025, 'Refining within-subject biological variation estimation using routine laboratory data: practical applications of the refineR algorithm', Clinical Chemistry and Laboratory Medicine, 63, pp. e146 - e149, http://dx.doi.org/10.1515/cclm-2024-1386

Sandhu G; Adattini J; Gordon EA; O'Neill N; Bagnis C; Chambers P; Martin JH; Flynn A; Ibrahim K; Jardine MJ; Johnson DW; Jones GRD; Karapetis CS; Kelly A; Kichenadasse G; Kliman DS; Liauw W; Lucas C; Mallett AJ; Malyszko J; Michael M; Pollock CA; Roberts DM; Rosner MH; Routledge DJM; Scuderi C; Shingleton J; Shortt J; Siderov J; Sprangers B; Stein BN; Tunnicliffe DJ; Webber K; Ward RL, 2025, 'Aligning kidney function assessment in patients with cancer to global practices in internal medicine', Eclinicalmedicine, 82, http://dx.doi.org/10.1016/j.eclinm.2025.103102

Røys EÅ; Viste K; Kellmann R; Guldhaug NA; Alaour B; Sylte MS; Torsvik J; Strand H; Marber M; Omland T; Theodorsson E; Jones GRD; Aakre KM, 2025, 'Estimating Reference Change Values Using Routine Patient Data: A Novel Pathology Database Approach', Clinical Chemistry, 71, pp. 307 - 318, http://dx.doi.org/10.1093/clinchem/hvae166

Barr ELM; Barzi F; Mills P; Nickels M; Graham S; Pearson O; Obeyesekere V; Hoy WE; Jones GRD; Lawton PD; Brown ADH; Thomas M; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ; Hughes JT, 2025, 'Cardiometabolic Biomarkers and Prediction of Kidney Disease Progression: The eGFR Cohort Study', Canadian Journal of Kidney Health and Disease, 12, http://dx.doi.org/10.1177/20543581251363126

Farrell CJL; Jones GRD; Sikaris KA; Badrick T; Graham P; Bush J, 2024, 'Sharing reference intervals and monitoring patients across laboratories - Findings from a likely commutable external quality assurance program', Clinical Chemistry and Laboratory Medicine, 62, pp. 2037 - 2047, http://dx.doi.org/10.1515/cclm-2024-0041

Jones GRD; Aarsand AK; Carobene A; Coskun A; Fernandez-Calle P; Bartlett B; Diaz-Garzon J; Sandberg S, 2024, 'A New Concept for Reference Change Values—Regression to the Population Mean', Clinical Chemistry, 70, pp. 1076 - 1084, http://dx.doi.org/10.1093/clinchem/hvae067

Kempton H; Jones G; McCready M; Kovacic J, 2024, 'Macrotroponin in the COVID-19 Era: An Under-Recognised Cause of Persistent Troponin Elevation', Heart Lung and Circulation, 33, pp. 1147 - 1150, http://dx.doi.org/10.1016/j.hlc.2024.03.007

Jones GRD; Bell KJL; Ceriotti F; Loh TP; Lord S; Sandberg S; Smith AF; Horvath AR, 2024, 'Applying the Milan models to setting analytical performance specifications - Considering all the information', Clinical Chemistry and Laboratory Medicine, 62, pp. 1531 - 1537, http://dx.doi.org/10.1515/cclm-2024-0104

Horvath AR; Bell KJL; Ceriotti F; Jones GRD; Loh TP; Lord S; Sandberg S, 2024, 'Outcome-based analytical performance specifications: current status and future challenges', Clinical Chemistry and Laboratory Medicine, 62, pp. 1474 - 1482, http://dx.doi.org/10.1515/cclm-2024-0125

Jones GRD, 2024, 'Using analytical performance specifications in a medical laboratory', Clinical Chemistry and Laboratory Medicine, 62, pp. 1512 - 1519, http://dx.doi.org/10.1515/cclm-2024-0102

MacIsaac R; Barr E; Barzi F; Mills P; Nickels M; Graham S; Obeyesekere V; Hoy W; Jones G; Lawton P; Brown A; Thomas M; Sinha A; Cass A; Hughes J; Maple-Brown L, 2024, 'WCN24-1077 NOVEL BIOMARKERS AND PREDICTION OF KIDNEY DISEASE PROGRESSION IN AUSTRALIAN FIRST NATION PEOPLE WITH AND WITHOUT DIABETES: THE eGFR STUDY', Kidney International Reports, 9, pp. s115, http://dx.doi.org/10.1016/j.ekir.2024.02.237

Kanis JA; Johansson H; McCloskey EV; Liu E; Åkesson KE; Anderson FA; Azagra R; Bager CL; Beaudart C; Bischoff-Ferrari HA; Biver E; Bruyère O; Cauley JA; Center JR; Chapurlat R; Christiansen C; Cooper C; Crandall CJ; Cummings SR; da Silva JAP; Dawson-Hughes B; Diez-Perez A; Dufour AB; Eisman JA; Elders PJM; Ferrari S; Fujita Y; Fujiwara S; Glüer CC; Goldshtein I; Goltzman D; Gudnason V; Hall J; Hans D; Hoff M; Hollick RJ; Huisman M; Iki M; Ish-Shalom S; Jones G; Karlsson MK; Khosla S; Kiel DP; Koh WP; Koromani F; Kotowicz MA; Kröger H; Kwok T; Lamy O; Langhammer A; Larijani B; Lippuner K; Mellström D; Merlijn T; Nordström A; Nordström P; O’Neill TW; Obermayer-Pietsch B; Ohlsson C; Orwoll ES; Pasco JA; Rivadeneira F; Schott AM; Shiroma EJ; Siggeirsdottir K; Simonsick EM; Sornay-Rendu E; Sund R; Swart KMA; Szulc P; Tamaki J; Torgerson DJ; van Schoor NM; van Staa TP; Vila J; Wareham NJ; Wright NC; Yoshimura N; Zillikens MC; Zwart M; Vandenput L; Harvey NC; Lorentzon M; Leslie WD, 2023, 'Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX', Osteoporosis International, 34, pp. 2027 - 2045, http://dx.doi.org/10.1007/s00198-023-06870-z

Farrell CJ; Jones G; Shepherd S; Tran D; Badrick T, 2023, 'Mass or molar units? Australia's drug problem persists', Pathology, 55, pp. 865 - 867, http://dx.doi.org/10.1016/j.pathol.2023.03.006

Jamieson EL; Dimeski G; Flatman R; Hickman PE; Ross Dallas Jones G; V Marley J; David McIntyre H; McNeil AR; Nolan CJ; Potter JM; Sweeting A; Ward P; Williams P; Rita Horvath A, 2023, 'Oral glucose tolerance test to diagnose gestational diabetes mellitus: Impact of variations in specimen handling', Clinical Biochemistry, 115, pp. 33 - 48, http://dx.doi.org/10.1016/j.clinbiochem.2022.10.002

Haeckel R; Adeli K; Jones G; Sikaris K; Wosniok W, 2023, 'Definitions and major prerequisites of direct and indirect approaches for estimating reference limits', Clinical Chemistry and Laboratory Medicine, 61, pp. 402 - 406, http://dx.doi.org/10.1515/cclm-2022-1061

Handelsman DJ; Jones G; Kouzios D; Desai R, 2023, 'Evaluation of testosterone, estradiol and progesterone immunoassay calibrators by liquid chromatography mass spectrometry', Clinical Chemistry and Laboratory Medicine, http://dx.doi.org/10.1515/cclm-2022-1179

Røys EÅ; Guldhaug NA; Viste K; Jones GD; Alaour B; Sylte MS; Torsvik J; Kellmann R; Strand H; Theodorsson E; Marber M; Omland T; Aakre KM, 2023, 'Sex Hormones and Adrenal Steroids: Biological Variation Estimated Using Direct and Indirect Methods', Clinical Chemistry, 69, pp. 100 - 109, http://dx.doi.org/10.1093/clinchem/hvac175

Hughes D; Byrnes E; Schneider HG; Jones GRD; Coates P; Campbell CA; Nascimento MP; Daley GM; Saleem M; Choy KW, 2023, 'Total Calcium and Adjusted Calcium: An Australasian Review of Current Evidence and Proposed Approaches', Clinical Biochemist Reviews, 43, pp. 65 - 78, http://dx.doi.org/10.33176/AACB-22-00005

Jones G; Farrell C; Sikaris K; Shepherd S; Bush J; Badrick T, 2023, 'Australia as one big laboratory – are our results good enough?', Pathology, 55, pp. S8 - S9, http://dx.doi.org/10.1016/j.pathol.2022.12.034

Boscato L; Graham P; Jones G; Ward P; Yen T, 2023, 'Final recommendations for macroprolactin', Pathology, 55, pp. S9 - S9, http://dx.doi.org/10.1016/j.pathol.2022.12.035

Radovanovic M; Day RO; Jones GDR; Galettis P; Norris RLG, 2022, 'LC–MS/MS method for simultaneous quantification of ten antibiotics in human plasma for routine therapeutic drug monitoring', Journal of Mass Spectrometry and Advances in the Clinical Lab, 26, pp. 48 - 59, http://dx.doi.org/10.1016/j.jmsacl.2022.11.001

Badrick T; Jones G; Miller WG; Panteghini M; Quintenz A; Sandberg S; Spannagl M, 2022, 'Differences between Educational and Regulatory External Quality Assurance/Proficiency Testing Schemes', Clinical Chemistry, 68, pp. 1238 - 1244, http://dx.doi.org/10.1093/clinchem/hvac132

Tickell AM; Rohleder C; Ho N; McHugh C; Jones G; Song YJC; Hickie IB; Scott EM, 2022, 'Identifying pathways to early-onset metabolic dysfunction, insulin resistance and inflammation in young adult inpatients with emerging affective and major mood disorders', Early Intervention in Psychiatry, 16, pp. 1121 - 1129, http://dx.doi.org/10.1111/eip.13260

Thomas DH; Warner JV; Jones GRD; Chung JZY; MacEy DJ; Screnci A; Ryan JB, 2022, 'Total bilirubin assay differences may cause inconsistent treatment decisions in neonatal hyperbilirubinaemia', Clinical Chemistry and Laboratory Medicine, 60, pp. 1736 - 1744, http://dx.doi.org/10.1515/cclm-2022-0749

Jones GRD; Chung JZY, 2022, 'The effect of acute changes in glomerular filtration rate on common biochemical tests', Practical Laboratory Medicine, 31, http://dx.doi.org/10.1016/j.plabm.2022.e00280

Badrick T; Miller WG; Panteghini M; Delatour V; Berghall H; MacKenzie F; Jones G, 2022, 'Interpreting EQA - Understanding Why Commutability of Materials Matters', Clinical Chemistry, 68, pp. 494 - 500, http://dx.doi.org/10.1093/clinchem/hvac002

Jones GRD; Delatour V; Badrick T, 2022, 'Metrological traceability and clinical traceability of laboratory results-the role of commutability in External Quality Assurance', Clinical Chemistry and Laboratory Medicine, 60, pp. 669 - 674, http://dx.doi.org/10.1515/cclm-2022-0038

Radovanovic M; Jones G; Day RO; Galettis P; Norris RLG, 2022, 'Mitigating analyte to stable isotope labelled internal standard cross-signal contribution in quantitative liquid chromatography-tandem mass spectrometry', Journal of Mass Spectrometry and Advances in the Clinical Lab, 24, pp. 57 - 64, http://dx.doi.org/10.1016/j.jmsacl.2022.04.002

Reuter SE; Stocker SL; Alffenaar JWC; Baldelli S; Cattaneo D; Jones G; Koch BCP; Kocic D; Mathew SK; Molinaro M; Neely M; Sandaradura I; Marriott DJE, 2022, 'Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement from the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology', Therapeutic Drug Monitoring, 44, pp. 121 - 132, http://dx.doi.org/10.1097/FTD.0000000000000944

Wong S; Reuter SE; Jones GRD; Stocker SL, 2022, 'Review and evaluation of vancomycin dosing guidelines for obese individuals', Expert Opinion on Drug Metabolism and Toxicology, 18, pp. 323 - 335, http://dx.doi.org/10.1080/17425255.2022.2098106

Roberts DM; Hughes HK; Haber PS; Jones GRD, 2022, 'Variability in insulin pharmacokinetics following high-dose insulin therapy', Clinical Toxicology, 60, pp. 389 - 391, http://dx.doi.org/10.1080/15563650.2021.1967372

Loh TP; Smith AF; Bell KJL; Lord SJ; Ceriotti F; Jones G; Bossuyt P; Sandberg S; Horvath AR, 2021, 'Setting analytical performance specifications using HbA1c as a model measurand', Clinica Chimica Acta, 523, pp. 407 - 414, http://dx.doi.org/10.1016/j.cca.2021.10.016

El-Khoury JM; Hoenig MP; Jones GRD; Lamb EJ; Parikh CR; Tolan NV; Wilson FP, 2021, 'AACC Guidance Document on Laboratory Investigation of Acute Kidney Injury', Journal of Applied Laboratory Medicine, 6, pp. 1316 - 1337, http://dx.doi.org/10.1093/jalm/jfab020

Ozarda Y; Ichihara K; Jones G; Streichert T; Ahmadian R, 2021, 'Comparison of reference intervals derived by direct and indirect methods based on compatible datasets obtained in Turkey', Clinica Chimica Acta, 520, pp. 186 - 195, http://dx.doi.org/10.1016/j.cca.2021.05.030

Imani S; Buscher H; Day R; Gentili S; Jones GRD; Marriott D; Norris R; Sandaradura I, 2021, 'Correction to: An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy (European Journal of Clinical Microbiology & Infectious Diseases, (2018), 37, 11, (2171-2175), 10.1007/s10096-018-3357-9)', European Journal of Clinical Microbiology and Infectious Diseases, 40, pp. 1789, http://dx.doi.org/10.1007/s10096-021-04291-6

Patel K; El-Khoury JM; Aarsand AK; Badrick T; Jones GRD; Sikaris K; Parnas ML, 2021, 'Current Utility and Reliability of Biological Variability', Clinical Chemistry, 67, pp. 1050 - 1055, http://dx.doi.org/10.1093/clinchem/hvab055

Cunio CB; Uster DW; Carland JE; Buscher H; Liu Z; Brett J; Stefani M; Jones GRD; Day RO; Wicha SG; Stocker SL, 2021, 'Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients', Clinical Microbiology and Infection, 27, pp. 783 - 783.e14, http://dx.doi.org/10.1016/j.cmi.2020.07.005

El-Khoury JM; Ovalle AA; Cervinski MA; Levey AS; Jones G; Eneanya ND; Lieske JC; Jha V, 2021, 'Is It Time to Move On? Reexamining Race in Glomerular Filtration Rate Equations', Clinical Chemistry, 67, pp. 585 - 591, http://dx.doi.org/10.1093/clinchem/hvaa333

Sikaris K; Koerbin G; Jones G; Flatman R, 2021, 'Reply to Dr Hawkins regarding comparability of results for monitoring', Clinical Chemistry and Laboratory Medicine, 59, pp. E221 - E222, http://dx.doi.org/10.1515/cclm-2020-0604

Mukerji S; Jones GRD, 2021, 'Uncertainty should not be neglected in potassium correction for haemolysis', Scandinavian Journal of Clinical and Laboratory Investigation, 81, pp. 423, http://dx.doi.org/10.1080/00365513.2021.1931710

Muir CA; Jones GRD; Greenfield JR; Weissberger A; Samaras K, 2020, 'THYROID PEROXIDASE ANTIBODY POSITIVITY IS ASSOCIATED with RELAPSE-FREE SURVIVAL following ANTITHYROID DRUG TREATMENT for GRAVES DISEASE', Endocrine Practice, 26, pp. 1026 - 1030, http://dx.doi.org/10.4158/EP-2020-0035

Badve SV; Pascoe EM; Tiku A; Boudville N; Brown FG; Cass A; Clarke P; Dalbeth N; Day RO; De Zoysa JR; Douglas B; Faull R; Harris DC; Hawley CM; Jones GRD; Kanellis J; Palmer SC; Perkovic V; Rangan GK; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Neal B, 2020, 'Effects of allopurinol on the progression of chronic kidney disease', New England Journal of Medicine, 382, pp. 2504 - 2513, http://dx.doi.org/10.1056/NEJMoa1915833

Muir CA; Greenfield JR; Weissberger A; Jones GRD; Samaras K, 2020, 'SAT-LB75 Thyroid Peroxidase Antibody Positivity Predicts Relapse Free Survival Following Anti-Thyroid Drug Treatment for Graves Disease', Journal of the Endocrine Society, 4, http://dx.doi.org/10.1210/jendso/bvaa046.2016

Back to profile page